



Bremelanotide (PT-141)
Vyleesi®
FDA-approved for acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women.
- Drug class
- Melanocortin receptor agonist
- How it is given
- Injection as needed, before sexual activity
- Prescription
- Required
- Dispensed by
- DiRx Inc. · licensed pharmacy
FDA status: Brand-name versions (Vyleesi®) are FDA-approved. If your doctor prescribes a compounded version, it is prepared by a licensed pharmacy for you and is not itself FDA-approved; your doctor and pharmacist explain which version you receive.
Pricing is shared after you speak with our team and a licensed doctor approves treatment. Clinics see pricing after account verification.
Can cause a temporary rise in blood pressure; not for people with uncontrolled high blood pressure or known heart disease. Common side effects include nausea, flushing and headache. Not approved for men or postmenopausal women.
This is not the complete list of risks. Read the full prescribing information and talk to your doctor. Official label (DailyMed) ↗
How to get started
- Message us on WhatsApp or call (954) 420-7747.
- Talk with a licensed doctor, who reviews your health history and decides if this medicine is right for you.
- If prescribed, our team shares pricing and a licensed pharmacy fills your order.
Videos: how it works and how it is used
Independent videos from doctors, hospitals and health educators on YouTube. They are for general education; your doctor gives the instructions for your treatment.
Vyleesi for the treatment of Low Libido in Premenopausal Women - TheFibroidDoc - Dr. Prabakar
Cheruba Prabakar, MD | TheFibroidDoc · YouTubeVyleesi (Bremelanotide)- generalized hypoactive sexual desire disorder (HSDD)
Pharmacy Talk USA · YouTubeWhat is Hypoactive Sexual Desire Disorder (HSDD) in Women? by Dr. Jessica Yih - UC Irvine Urology
UCI Urology · YouTubeHypoactive Sexual Desire Disorder HSDD—Open the Door to Discussion
MenopauseSociety · YouTubeOther treatments
Semaglutide
Ozempic® · Wegovy®Weekly GLP-1 medicine for type 2 diabetes and chronic weight management.
Tirzepatide
Mounjaro® · Zepbound®Weekly dual-action medicine for type 2 diabetes, weight management and sleep apnea.
Liraglutide
Victoza® · Saxenda®Daily GLP-1 medicine for type 2 diabetes and weight management.
Talk to a real person today.
No forms, no checkout. Message us on WhatsApp or call, and our team will guide you through the next step.